אקסטנדי 40 מ"ג - Xtandi 40 mg: הבדלים בין גרסאות

Xtandi is indicated for:• the treatment of adult men with metastatic castration-resistant prostate cancer who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated • the treatment of adult men with metastatic castration resistant prostate cancer whose disease has progressed on or after docetaxel therapy.